Quest Diagnostics Completes Acquisition of Haystack Oncology
by Healthcare M&A 06/23/2023 Leave a Comment
What You Should Know:
Quest Diagnostics announced that it has completed its $450M acquisition of Haystack Oncology.Haystack Oncology has developed a highly sensitive minimal-residual disease (MRD) testing technology, based…
Continue Reading